Fischer Imaging Corporati (FIMG.PK)

Fischer Imaging Corporation and its subsidiaries engage in the manufacture and service of specialty digital imaging systems and other medical devices primarily used in screening, diagnostic, and interventional procedures. It also engages in the manufacture and sale of MammoTest to a single distributor in Europe. In addition, the company services and sells products that meet selected needs of the broader radiology and electrophysiology markets. Its breast cancer diagnostic product line includes SenoScan digital mammography system, which is developed for screening and diagnostic mammography; and MammoTest prone stereotactic breast biopsy system. The company's radiology, electrophysiology and surgery product lines consist of film and digital general radiology systems, electrophysiology stimulation system, electrophysiology x-ray imaging systems, and specialized surgical C-arm system. It markets and supports its products primarily through its subsidiaries and various dealers in the United States, Mexico, Europe, and internationally. Fischer Imaging was founded by H.G. Fischer in 1910 and is headquartered in Dever, Colorado.

For the six months ended 30 June 2006, Fischer Imaging Corporation's revenues decreased 51% to $12.5M. Net loss decreased 79% to $3.3M. Revenues reflect decreased SenoScan digital mammography product revenue, lower revenues from MammoTest breast biopsy products and decreased revenue from RE&S products. Lower loss reflects the absence of selling & marketing expenses, R & D expenses and increased interest income.